Found: 30
Select item for more details and to access through your institution.
Final analysis from RESONATE: Up to six years of follow‐up on ibrutinib in patients with previously treated chronic lymphocytic leukemia or small lymphocytic lymphoma.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 12, p. 1353, doi. 10.1002/ajh.25638
- By:
- Publication type:
- Article
Ibrutinib‐associated invasive fungal diseases in patients with chronic lymphocytic leukaemia and non‐Hodgkin lymphoma: An observational study.
- Published in:
- Mycoses, 2019, v. 62, n. 12, p. 1140, doi. 10.1111/myc.13001
- By:
- Publication type:
- Article
Immunoglobulin replacement therapy in chronic lymphocytic leukaemia patients with hypogammaglobulinaemia and infection.
- Published in:
- European Journal of Haematology, 2022, v. 108, n. 6, p. 460, doi. 10.1111/ejh.13754
- By:
- Publication type:
- Article
Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) with 17p Deletion: Outcome and Minimal Residual Disease (MRD) from the Full Population of the Pivotal M13-982 Trial.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S303, doi. 10.1016/j.clml.2017.07.098
- By:
- Publication type:
- Article
Profiles of Surface Mosaics on Chronic Lymphocytic Leukemias Distinguish Stable and Progressive Subtypes.
- Published in:
- Journal of Pharmacy & Pharmaceutical Sciences, 2013, v. 16, n. 2, p. 231, doi. 10.18433/j3f01c
- By:
- Publication type:
- Article
Improving outcomes for patients with lymphoma: design and development of the Australian and New Zealand Lymphoma and Related Diseases Registry.
- Published in:
- 2022
- By:
- Publication type:
- journal article
The novel Hsp-90 inhibitor SNX7081 is significantly more potent than 17-AAG against primary CLL cells and a range of haematological cell lines, irrespective of lesions in the TP53 pathway.
- Published in:
- British Journal of Haematology, 2010, v. 151, n. 2, p. 185, doi. 10.1111/j.1365-2141.2010.08348.x
- By:
- Publication type:
- Article
Analysis of human leukaemias and lymphomas using extensive immunophenotypes from an antibody microarray.
- Published in:
- British Journal of Haematology, 2006, v. 135, n. 2, p. 184, doi. 10.1111/j.1365-2141.2006.06266.x
- By:
- Publication type:
- Article
Second primary malignancies in chronic lymphocytic leukaemia: Skin, solid organ, haematological and Richter's syndrome.
- Published in:
- EJHaem, 2022, v. 3, n. 1, p. 129, doi. 10.1002/jha2.366
- By:
- Publication type:
- Article
The ClpP activator ONC‐212 (TR‐31) inhibits BCL2 and B‐cell receptor signaling in CLL.
- Published in:
- EJHaem, 2021, v. 2, n. 1, p. 81, doi. 10.1002/jha2.160
- By:
- Publication type:
- Article
Extensive surface protein profiles of extracellular vesicles from cancer cells may provide diagnostic signatures from blood samples.
- Published in:
- Journal of Extracellular Vesicles, 2016, v. 5, p. 1, doi. 10.3402/jev.v5.25355
- By:
- Publication type:
- Article
Repeated COVID‐19 vaccination to maximum antibody response yields very low mortality and hospitalisation rates in patients with CLL and MBL.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 2, p. 487, doi. 10.1111/bjh.19087
- By:
- Publication type:
- Article
Ibrutinib use, treatment duration, and concomitant medications in Australian patients with relapsed or refractory chronic lymphocytic leukaemia.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 4, p. 790, doi. 10.1111/bjh.18306
- By:
- Publication type:
- Article
COVID‐19 vaccine failure in chronic lymphocytic leukaemia and monoclonal B‐lymphocytosis; humoural and cellular immunity.
- Published in:
- British Journal of Haematology, 2022, v. 197, n. 1, p. 41, doi. 10.1111/bjh.18014
- By:
- Publication type:
- Article
Insight into del17p low‐frequency subclones in chronic lymphocytic leukaemia (CLL): data from the Australasian Leukaemia and Lymphoma Group (ALLG)/CLL Australian Research Consortium (CLLARC) CLL5 trial.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 3, p. 556, doi. 10.1111/bjh.17394
- By:
- Publication type:
- Article
Molecular pathogenesis of chronic lymphocytic leukaemia.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 5, p. 668, doi. 10.1111/bjh.16102
- By:
- Publication type:
- Article
MEK1/2 inhibition by binimetinib is effective as a single agent and potentiates the actions of Venetoclax and ABT‐737 under conditions that mimic the chronic lymphocytic leukaemia (CLL) tumour microenvironment.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 3, p. 360, doi. 10.1111/bjh.15282
- By:
- Publication type:
- Article
Humoral immune failure defined by immunoglobulin class and immunoglobulin G subclass deficiency is associated with shorter treatment‐free and overall survival in Chronic Lymphocytic Leukaemia.
- Published in:
- British Journal of Haematology, 2018, v. 181, n. 1, p. 97, doi. 10.1111/bjh.15146
- By:
- Publication type:
- Article
Atrial fibrillation, anticoagulant stroke prophylaxis and bleeding risk with ibrutinib therapy for chronic lymphocytic leukaemia and lymphoproliferative disorders.
- Published in:
- 2016
- By:
- Publication type:
- Editorial
Chronic lymphocytic leukaemia, monoclonal B-lymphocytosis and pregnancy: five cases, a literature review and discussion of management.
- Published in:
- British Journal of Haematology, 2015, v. 168, n. 3, p. 350, doi. 10.1111/bjh.13134
- By:
- Publication type:
- Article
Identification of repertoires of surface antigens on leukemias using an antibody microarray.
- Published in:
- Proteomics, 2003, v. 3, n. 11, p. 2147, doi. 10.1002/pmic.200300599
- By:
- Publication type:
- Article
How to Improve Your TEAMING AGREEMENT, Part 2 of 2.
- Published in:
- Contract Management, 2015, v. 55, n. 3, p. 34
- By:
- Publication type:
- Article
How to Improve Your TEAMING AGREEMENT: PART 1 OF 2.
- Published in:
- Contract Management, 2015, v. 55, n. 2, p. 54
- By:
- Publication type:
- Article
Cladribine and Fludarabine Nucleoside Change the Levels of CD Antigens on B-Lymphoproliferative Disorders.
- Published in:
- International Journal of Proteomics, 2010, p. 1, doi. 10.1155/2010/964251
- By:
- Publication type:
- Article
Metastatic squamous cell carcinoma in chronic lymphocytic leukaemia in a haematology–dermatology multidisciplinary clinic.
- Published in:
- Australasian Journal of Dermatology, 2023, v. 64, n. 2, p. 291, doi. 10.1111/ajd.13994
- By:
- Publication type:
- Article
Fludarabine nucleoside induces accumulations of p53, p63 and p73 in the nuclei of human B-lymphoid cell lines, with cytosolic and mitochondrial increases in p53.
- Published in:
- Proteomics - Clinical Applications, 2012, v. 6, n. 5/6, p. 279, doi. 10.1002/prca.201200003
- By:
- Publication type:
- Article
B-cell chronic lymphocytic leukaemia with CD8 expression: report of 10 cases and immunochemical analysis of the CD8 antigen.
- Published in:
- British Journal of Haematology, 1998, v. 103, n. 1, p. 157, doi. 10.1046/j.1365-2141.1998.00928.x
- By:
- Publication type:
- Article
Splenic lymphoma with villous lymphocytes: natural history and response to therapy in 50 cases.
- Published in:
- British Journal of Haematology, 1991, v. 78, n. 2, p. 206, doi. 10.1111/j.1365-2141.1991.tb04417.x
- By:
- Publication type:
- Article
Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidance.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Profiling CD antigens on leukaemias with an antibody microarray
- Published in:
- FEBS Letters, 2009, v. 583, n. 11, p. 1785, doi. 10.1016/j.febslet.2009.03.018
- By:
- Publication type:
- Article